





? ? ?? ?? Ikuo Saiki 
??? ?? ?? Hiroaki Sakurai 
? ? ?? ?? Keiichi Koizumi 
 
? ? ? 
1)  Yamada H. and Saiki I. (eds.) Traditional Herbal Medicines for Modern Times Volume 5, “Juzen-taiho-to 
(Shi-Quan-Da-Bu-Tang)” Scientific Evaluation and Clinical Applications, pp1-242, CRC Press Taylor & Francis Group, Boca 
Raton, FL, USA, 2005.  
2)  ?????????????????????????SBO38: ??????????????????????
?????????????????? ? 13? ???????, ? III? ????????????????
?? ????? ???????????????? ???????????? 3????????pp259-262?
2005? 
3)  ????????????????????? ??, ????????? ?? III ?????? ?????
????pp231-242?2005? 
4)  ??????. ?????????????,???????????????????????? ????, ?
???????????pp125-132?2005? 
 
? ? ? 
1)  Singhirunnusorn P., Suzuki S., Kawasaki N., Saiki I., and Sakurai H.: Critical roles of threonine-187 phosphorylation in cellular 
stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling 
complex containing TAK1-binding protein TAB1 and TAB2. J. Biol. Chem. 280: 7359-7368, 2005.  
2)  Chino A, Sakurai H., Matsuo M., Choo M-K., Koizumi K., Shimada Y., Terasawa K., and Saiki I.: Juzentaihoto, a Kampo 
medicine, enhances IL-12 production by modulating Toll-like receptor 4 signalling pathways in murine peritoneal exudates 
macrophages. Int. Immunopharmacol., 5: 871-882, 2005. 
3)  Yoshioka I., Tsuchiya Y., Aozuka Y., Ohnishi Y., Sakurai H., Koizumi K., Tsukada K., and Saiki I.: Urinary trypsin inhibitor 
suppresses surgical stress-facillitated lung metastasis of murine colon cell carcinoma, colon 26-L5 cells. Anticancer Res., 25: 
815-820, 2005. 
4)  Lirdprapamongkol K, Sakurai H., Kawasaki N., Choo M-K, Saitoh Y., Aozuka Y., Singhirunnusorn P., Ruchirawat S., Svasti J., 
and Saiki I.: Vanillin suppresses tumor invasion and metastasis of breast cancer cells. Eur. J. Pharm. Sci., 25: 57-65, 2005. 
5)  Nagakawa O., Junicho A., Akashi T., Koizumi K., Matsuda T., Fuse H., and Saiki I.: Vasoactive intestinal peptide and pituitary 
adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer and prostatic epithelial cells. 
Oncology Rep., 23: 1217-1221, 2005. 
6)  Ueno Y., Sakurai H., Matsuo M., Choo M-K., Koizumi K., and Saiki I.: Selective inhibition of TNF-α-induced activation of 
mitogen-activated protein kinases and metastatic activities by gefitinib. Br. J. Cancer, 92: 1690-1695, 2005. 
7)  Kiga C., Nakagawa T., Koizumi K., Sakurai H., Shibagaki Y., Ogawa K., Goto H., and Saiki I.: Expression pattern of plasma 
proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI 
ProteinChip platform. Biol. Pharm. Bull., 28: 1031-1037, 2005. 
8)  Goto H., Kiga C., Nakagawa T., Koizumi K., Sakurai H., Shibagaki Y. Ogawa K., Shibahara N., Shimada Y., and Saiki I.: 
Effects of two formulations for overcoming oketsu on vascular function and expression patterns of plasma proteins in 
spontaneously diabetic rats. J. Trad. Med., 22: 237-243, 2005. 
9)  Tega E., Kiga C. Chino A., Sakurai H., Koizumi K., Tani T., and Saiki I.: A newly devised formulation for self-medication 
enhances interferon- production and proliferation of splenic lymphocytes. Biol. Pharm. Bull., 28: 1869-1872, 2005. 
10)  Schwabe R.F., and Sakurai H.: IKK phosphorylates p65 at S468 in transactivation domain 2. FASEB J., 19: 1758-1760, 2005. 
11)  Choo M-K., Sakurai H., Koizumi K., and Saiki I.: Stimulation of cultured colon 26 cells with TNF-D promotes lung metastasis 
through the extracellular signal-regulated kinase pathway. Cancer Lett., 230: 47-56, 2005. 
12)  Sakurai H., Singhirunnusorn P., Shimotabira E., Chino A., Suzuki S., Koizumi K., and Saiki I.: TAK1-mediated transcriptional 
activation of CD28-responsive element and AP-1-binding site within the IL-2 promoter in Jurkat T cells. FEBS Lett., 579: 
6641-6646, 2005. 
13)  Ueda Y., Yamagishi T., Samata K., Hirayama N., Aozuka Y., Tanaka M., Nakaike S., and Saiki I.: Anti-tumor effect of synthetic 
VEGF binding antagonist, VGA1155. Anticancer Res., 25: 3973-3977, 2005. 
14)  Shinohara H., Yasuda T., Aiba Y., Sanjo H., Hamadate M., Watarai H., Sakurai H., and Kurosaki T.: PKC regulates 
BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J. Exp. Med., 202: 1423-1431, 
2005. 
15)  Blonska M., Shambharkar P.B., Kobayashi M., Zhang D., Sakurai H. Su B. and Lin X.: TAK1 is recruited to the tumor necrosis 
factor-alpha (TNF-D) receptor 1 in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading 
to NF-NB activation. J. Biol. Chem., 280: 43056-43063, 2005. 
 
? ? ? 
1)  ???????????????????????????????5. ?????????????? Frontiers in 
Cancer Treatment, 17: 39-44, 2005. 
2)  ????????????????? 34???????????????2????? I ????????????
????????????Seminarria Dermatologie, 176: 44-48, 2005. 
3)  ????????????????????????????−?????????????????????? ?
??????? 56: 414-420, 2005. 
4)  ??????? ????????????????????? −?????????????????−???
75: 842-845, 2005. 
5)  ??????????????? ????????????????? −????−?????????????
???Animus?????????????39: 35-40, 2005. 
6)  ?????????????? 7 ?????????????????????????????????? 9: 48,  
2005. 
7)  ?????????????????????????????? 20: 380-388, 2005. 
8)  ???????????????????????????????????????????????????
????? 18: 298-312, 2005.  
 
? ???? 
1)  Sakurai H., Choo M-K., Koizumi, K., and Saiki, I.: Stimulation of cultured colon 26 cells with TNF-D promoting lung 
metastasis through the ERK, JNK and p38 MAPK pathways. Inflammation and Cancer. Keystone Symposium, 2005, 2-3, USA. 










6)  ????????? II?????????????????????? 46???????????2005?5????  
7)  ????????????????????????????????????????????????????
??? 56???????????2005?5???? 
8)  ?????Singhirunnusorn Pattama?Choo Min-Kyung????????????????????????????
??? TAK1??????????????????? 23?????????????2005?5???? 
9)  ????????????????????????????????????Aminopeptidase N ???????
??????????????????? 14??????????2005?6???? 
10)  Choo Min-Kyung?????????????????????????????? TAK1???????????
???? 14??????????2005?6????  
11)  ????????????????????Choo Min-Kyung???????????????????? CXCL1
??????????????????????????????? 14??????????2005?6???? 
12)  ? ????????Choo Min-Kyung???????????????????????????????????
? 14??????????2005?6???? 
13)  ?????????????????????? ??????????????????CXCR4???????
????????? 14??????????2005?6???? 
14)  ??????????Choo Min-Kyung???????????????????? TNF-D???????????
????? gefitinib????? 14??????????2005?6???? 
15)  ??????????????????????????? CX3CL1????????????????????
??????????? 9?????????????2005?6-7???? 
16)  ???????????????TNF-D????????????? TAK1 ??????????????? 9 ?
????????????2005?6-7???? 
17)  Nakamura E.S., Kobayashi M., Koizumi K., and Saiki I.: Secretion of CCL22/Macrophage-derived Chemokine (MDC) via 
RANKL-induced Osteoclast Differentiation Potentially Promotes Bone Metastasis of Lung Cancer. The 34th Annual Meeting 
of Brazilian Society of Biochemistry and Molecular Biology (SBBq). 2005, 7, Brazil. 
18)  ????????????????????????????????? 51?????????????2005?7? 
??? 
19)  Saiki I.: Proteomic analysis of pathogenic alyeration (Sho, ?) diagnosed by Kampo medicine and establishment of 
tailor-made treatment, The 10th International Symposium on Traditional Medicine in Toyama 2005:  The latest development 
of traditional medicine: harmonization and specificity, traditional knowledge and new technology, 2005, 7, Toyama. 
20)  Sakurai H., Mori A., Choo M-K., Obi R., Koizumi K., and Saiki I.: Marked increase in pulmonary metastasis in diabetic and 
obese mice. “Toward Personalized Medicine in Cancer and Other Life style-related diseases”. The 25th International 
Symposium of the Sapporo Cancer Seminar Foundation in Yamagata, 2005, 8, Yamagata. 
21)  ??????????????????????????????????????????? ??????????
???????????????????—WBN/Kob ??????????????????????????
???—?? 22????????2005?8???? 
22)  ????????????????? ?????????????? ?????????? ???????
??????????????????????? DHT-AR????????????????????????
???????? 64?????????2005?9???? 
23)  ?????????????????????? ????????????????????????????
??????????????????????????? 64?????????2005?9???? 
24)  ???????????????????????????????????? ??????????????
???? CCL22???????????? SBC-5????????????? 64?????????2005?9??
?? 
25)  ?????????????????????? ????????????CCL21?????????????
???????????????????? CCR7?????????? 64?????????2005?9???? 
26)  ???????????????????????????????? ????????? ???????Chemokine 
Receptor CXCR4?????????????????? 64?????????2005?9???? 
27)  ????????????????? ?????????????????? EGFR?????????????
? 64?????????2005?9???? 
28)  ?????Pattama Singhirunnusorn????????????????TNF-D??? TAK1 ??????? Thr-187
?????????? 64?????????2005?9???? 
29)  ? ????????Choo Min-Kyung??????????????????????????????????
????? 64?????????2005?9???? 
30)  ?? ??????????????????????????????????????? HAI-1??????
????? 64?????????2005?9???? 
31)  ?????????????????????????????????????? ????????????
SV40 T-antigen????????????????????????????????????????? 65??
????????2005?10???? 
32)  Goto H., Kiga C., Nakagawa T., Koizumi K., Sakurai H., Shibagaki Y., Ogawa K., Shibahara N., Shimada Y., and Saiki I.: 
Effects of two formulations for overcoming oketsu on vascular function and expression patterns of plasma proteins in 
spontaneously diabetic rats. The 13th International Congress of Oriental Medicine, 2005, 10, Daegu, Korea. 
33)  ????????????? ????????? ????????? ??????????????????
????????????????????????????????????????????? 43?????
??????2005?10????? 
34)  ??????????????????????????????? ???????????????????
?????????????????? 8??????????2005?11???? 
35)  ????????????????????????????????? SelpinE2????????? NF-NB p65
??????????? 28??????????2005?12???? 
36)  ????, Min-Kyung Choo, ????, ?????TNF-D????????????? TAK1??????????
???????? 28??????????2005?12????  
37)  Pattama Singhirunnusorn, Emi Shimotabira, Atsushi Chino, Shunsuke Suzuki, Keiichi Koizumi, Ikuo Saiki, Hiroaki Sakurai: 
TAK1-mediated transcriptional activation of CD28-responsive element and AP-1 site within the IL-2 promoter in Jurkat T cells. 
? 28??????????2005?12???? 




1)  ?????????????????????????2005?1?4??????? 
2)  ???????????????, ???????????2005?1?19?????? 




5)  ?????????????????????????????????????2005?1???? 
6)  ?????? 34???????????????2??????????????????????????????
?????????????? NIKKEI?2005?2????   
7)  ?????????????????????????????????????−??????????????
??????????????????−?2005?2????  
8)  ????????????????????????????????? 2003 (IV)?2005?2????  
9)  ????? FBRA ?????????????????????????????? 12? FBRA??????2005?
2????  
10)  Saiki I.: Inhibition of tumor metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue green 
alga Sipirulina platensis. Sipirulina Seminer, 2005, 2, Bangkok, Thai. 
11)  ???????????????????, ????????2005?2?25???????? 
12)  ????????????????? 16?????????????2005?2???? 
13)  ?????? 34???????????????2??????????????????????????????
???????????BS??? NIKKEI?2005?3???? 
14)  ?????????????????????????? ????????????2005?3????? 
15)  ???????????????? 15???? ?????????2005?3???? 
16)  ??????? ?????????????????????????????????? ??????????
2005?3???? 
17)  Saiki I.: Proteomic analysis of pathogenic alteration (Sho, ?) diagnosed by Kampo medicine and establishment if Tailor-made 
treatment. International Conference on the Eastern Medicine –China–Japan–Korea–, 2005, 4, Korea. 
18)  ??????????????? 11???????????2005?4???? 
19)  ??????????????????????????????????????????2005?6???? 
20)  ??????????????????????????? 1?????????????2005?7???? 
21)  ????????????????????????????????????????2005?7???? 
22)  ?? ????1????????????????????????????????????2?????????
???????????? 1?????????????2005?8????  
23)  ?????????????????????????????????????? 7???????????" ?
?????????????"?2005?8???? 
24)  ???????????????????????????????????? 2???????????2005?9?
??? 
25)  ?????????????????????????????? 30????????????2005?9????? 
26)  ???????????????−????????−????? ???????? ? 16???????2005?9?
??? 




29)  ????????? II?????????????????????? 21 ??????????????????
2005?10???? 
30)  ???????????????????????????2005?10?17?????? 
31)  ???????????−???????????−?????????????????????2005?10???? 
32)  ???????????????? 8?????????????????????? ?????2005?10???? 
33)  ???????? 21?? COE????? ?????? ???????????????????2005?11?07?
?????????? 
34)  ???????????????????????????? 15??????????????????2005?11?
??? 
35)  ????? NF-NB and MAPKs as targets for herbal medicines?????????????????????2005?11?
?????? 
36)  ??????????????????????? 130???? ????????????2005?11???? 
37)  ????????????????????????????????−???????????????????
??? User Meeting?2005?11???? 
38)  ???????????????? 7???????? ???2005?12???? 
39)  ????????????????????−????−???????????????????????????
???2005?12???? 
